BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors	DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Infections, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Tumor Virus Infections, adenocarcinoma, carcinoma, cutaneous neuroendocrine carcinoma, epithelial neoplasm, hepatocellular carcinoma, liposarcoma, liver disorder, myxoid liposarcoma, myxoid/round cell liposarcoma, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, polyomavirus infectious disease, primitive neuroectodermal tumor, sarcoma, squamous cell lung carcinoma, viral infectious disease	Active, not recruiting	Phase 1 / Phase 2	2025-12-05		NCT05120271

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
SOTIO Biotech a.s.	3
SOTIO Biotech AG	2
Sotio Biotech Inc.	1

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Baylor Scott and White Research Institute	Dallas	United States	5
Beatson Institute for Cancer Research Wolfson Wohl Cancer Research Centre	Glasgow	United Kingdom	1
Fred Hutchinson Cancer Center - Seattle Cancer Care Alliance (SCCA) Location	Seattle	United States	3
Froedtert and Medical College of Wisconsin	Milwaukee	United States	7
Hoag Hospital Newport Beach	Newport Beach	United States	5
The Royal Marsden NHS Foundation Trust	London	United Kingdom	41
University College London Hospitals NHS Foundation Trust	London	United Kingdom	21
University of Texas MD Anderson Cancer Center	Houston	United States	2